News & Insights

Stay Informed With Our Latest Updates

Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.

Insights > Keyword
Insights > Type
Global > Practices
Global > Industries
Insights > Location
Insights > Person
Insights > Date Filter
4370 Results Found

Firm News July 27, 2026

Gibson Dunn Advises Consortium Formed by KKR and Energy Capital Partners on $7.68 Billion Recommended Offer for FTSE 100 DCC Energy plc

Gibson Dunn is acting as counsel to global investment firm KKR, as well as co-counsel to the consortium formed by KKR and Energy Capital Partners, on KKR’s largest public-to-private transaction in Europe in more than a decade — the proposed acquisition of DCC Energy plc.

Firm News June 2, 2026

Gibson Dunn Advised KKR on Investment in Fresha.com

Gibson Dunn advised KKR on its investment in Fresha.com Holding Inc., the leading marketplace and software platform for the beauty, wellness, and self-care industry, at a valuation of over $1 billion.

Firm News May 5, 2026

Gibson Dunn Advised KKR as Lead Investor in $125 Million Series C Funding Round of Reserv

Gibson Dunn advised KKR as lead investor in the $125 million Series C funding round of Reserv Inc.

Firm News January 30, 2026

Gibson Dunn Advised EQT on Mews Systems B.V. Investment

Gibson Dunn advised global investor EQT on its investment in Mews Systems B.V., a leading hospitality technology company.

Firm News January 14, 2026

Gibson Dunn Advises Immedica Pharma on Acquisition of Neurocrine Group

Gibson Dunn is advising Immedica Pharma AB on the acquisition of Neurocrine Group Limited.

Firm News December 9, 2025

Gibson Dunn Advised KKR on Saviynt’s $700 Million Growth Equity Financing at Approximately $3 Billion Valuation 

Gibson Dunn advised KKR on Saviynt’s $700 million Growth Equity Financing at a valuation of approximately $3 billion

Firm News October 14, 2025

Gibson Dunn Advises KKR on Participation in Series A Financing Round of Expedition Therapeutics

Gibson Dunn advised KKR in connection with its participation in the Series A financing round of Expedition Therapeutics, Inc., an …

Client Alert February 23, 2024

Revised Market Definition Notice Gives European Commission Increased Flexibility in Competition Assessments

The European Commission has revised its Market Definition Notice, softening the rigidity of the Commission’s earlier approach and granting it more flexibility in competition assessments, particularly in relation to digital and R&D intensive markets.